Orthophor

Orthophor is a biotechnology company focused on developing advanced solutions for bone regeneration and orthopedic repair. The company's core technology, Phor-Fuse, is a synthetic, injectable, and biodegradable hydrogel platform designed to deliver therapeutic agents like Bone Morphogenetic Protein 2 (BMP-2) directly to fracture sites. By providing a controlled-release mechanism, Orthophor aims to enhance the natural healing process while minimizing the side effects typically associated with high-dose systemic treatments. Their pipeline primarily targets complex bone fractures, spinal fusion, and other conditions requiring accelerated osteogenesis. Orthophor's approach combines material science with biological signaling to address significant unmet needs in the orthopedic and trauma markets.